OnCore Manufacturing, LLC, a global supplier of electronic manufacturing
services to medical device OEMs, today announced the opening of its
first medical Center-of-Excellence (COE), located at its Fremont,
California facility. Designed to meet customers' requirements for
advanced medical device design and electronic manufacturing and assembly
services the facility will combine the company's core expertise of
managing highly complex medical product manufacturing and assembly with
the company's medical product design services, all cGMP compliant.
OnCore's Fremont Medical Center of Excellence (Photo: Business Wire)
"For over twenty years the medical device market has been one of the
three markets OnCore was created to serve. The company has continually
enhanced the services offered our medical customers to address their
evolving product lifecycle requirements. OnCore's Medical COE makes it
easier for our customers to engage the breadth of exsting and expanded
services by providing a 'one-stop-shop'", said Sajjad Malik, President
and CEO of OnCore. Malik also said, "OnCore's integrated solution has
proven time and again to significantly accelerate our customers' product
innovation cycles and reduce their time-to-market."
"The state-of-the-art COE facility provides Oraya with our own IP-secure
assembly area that's cleanroom-ready, which when coupled with OnCore's
product transfer process helps us meet our time-to-market date," said
Jim Taylor, CEO of Oraya Therapeutics. Taylor also said, "We have found
OnCore very flexible in meeting Oraya's changing requirements. This is
one of the many attributes we are look for in a partner."
OnCore Manufacturing, LLC is a leading provider of product
commercialization services for low-medium volume, high-complexity
products to international blue-chip aerospace and defense, industrial,
and medical companies. With manufacturing facilities in Springfield and
Wilmington, MA, Longmont, CO, San Marcos, Fremont and San Jose, CA,
Suzhou, China and Tijuana, Mexico, OnCore manages customers'
high-complexity products while providing them maximum flexibility to
manage their business in a close, collaborative relationship. More
information is available at www.oncorems.com.
OnCore is an equal opportunity employer.
Oraya Therapeutics, Inc. is a privately-held company developing
innovative and non-invasive therapies for diseases of the eye. The
company was founded in 2007. Its investors include Essex Woodlands
Health Ventures, Domain Associates, Scale Venture Partners, and Synergy
Life Science Partners. More information about Oraya Therapeutics can be
found at www.orayainc.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130207006774/en/
[ Back To NFVZone's Homepage ]